Michael Linn

Soluplus® as an effective absorption enhancer of poorly soluble drugs in vitro and in vivo

Michael Linn, Eva-Maria Collnot, Dejan Djurić et al. · European Journal of Pharmaceutical Sciences · 2011 · 240 citations

Pharmacy, Pharmaceutics, Pharmacology +14

Preclinical Profile of a Potent γ-Secretase Inhibitor Targeting Notch Signaling with <i>In vivo</i> Efficacy and Pharmacodynamic Properties

Leopoldo Luistro, Wei He, Melissa Smith et al. · Cancer Research · 2009 · 191 citations · Full text

Medicine, Oncology, Pharmacology +16

Antitumor activity of erlotinib (OSI-774, Tarceva) alone or in combination in human non-small cell lung cancer tumor xenograft models

Brian Higgins, Kenneth Kolinsky, Melissa Smith et al. · Anti-Cancer Drugs · 2004 · 153 citations

Medicine, Oncology, Pharmacology +14

Preclinical Optimization of MDM2 Antagonist Scheduling for Cancer Treatment by Using a Model-Based Approach

Brian Higgins, Kelli Glenn, Antje‐Christine Walz et al. · Clinical Cancer Research · 2014 · 62 citations · Full text

Medicine, Oncology, Pharmacology +17

The differential role of α1- and α5-containing GABAA receptors in mediating diazepam effects on spontaneous locomotor activity and water-maze learning and memory in rats

Miroslav M. Savić, Marija Milinković, Sundari Rallapalli et al. · The International Journal of Neuropsychopharmacology · 2009 · 59 citations · Full text

Medicine, Neuroscience, Pharmacology +14